Literature DB >> 15166293

Melanin-concentrating hormone receptor mutations and human obesity: functional analysis.

William T Gibson1, Pavlos Pissios, Daniel J Trombly, Jian'an Luan, Julia Keogh, Nicholas J Wareham, Eleftheria Maratos-Flier, Stephen O'Rahilly, I Sadaf Farooqi.   

Abstract

Melanin-concentrating hormone (MCH), a neuropeptide highly expressed in the lateral hypothalamus, has an important role in the regulation of energy balance and body weight in rodents. We examined whether mutations in the two known MCH receptors might be associated with obesity-related phenotypes in humans. Among 106 subjects with severe early onset obesity and a history of hyperphagia, we found two missense variants in MCHR1: Y181H and R248Q. Neither of these was found in 192 normal weight controls. R248Q cosegregated with obesity across two generations; family data were unavailable for Y181H. When expressed in HEK293 cells, R248Q showed no evidence of constitutive activation or ligand hypersensitivity for extracellular signal-regulated kinase phosphorylation. In addition, R248Q showed no enhanced suppression of cAMP generation. Two common single-nucleotide polymorphisms were found to be in linkage disequilibrium: g.-114A>G and c.39C>T. No association between either of these single-nucleotide polymorphisms and obesity-related phenotypes was found among a population cohort of 541 whites. Only two rare noncoding variants were found in MCHR2. In conclusion, mutations in the MCH receptors are not commonly found in humans with severe early onset obesity. Clarification of the relationship of these variants to obesity must await study in other populations and/or in genetically modified mice. Copyright 2004 NAASO

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166293     DOI: 10.1038/oby.2004.89

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  15 in total

1.  Genetics of fat tissue accumulation in pigs: a comparative approach.

Authors:  M Switonski; M Stachowiak; J Cieslak; M Bartz; M Grzes
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signaling.

Authors:  Carmit Goldstein; Jonathan C Schroeder; Jean-Philippe Fortin; Jennifer M Goss; Scott E Schaus; Martin Beinborn; Alan S Kopin
Journal:  J Pharmacol Exp Ther       Date:  2010-09-10       Impact factor: 4.030

Review 3.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

4.  Peptide-cleaving catalyst selective for melanin-concentrating hormone: Oxidative decarboxylation of N-terminal aspartate catalyzed by Co(III)cyclen.

Authors:  Min Gyum Kim; Myoung-soon Kim; Seong Du Lee; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2006-07-13       Impact factor: 3.358

Review 5.  GENETIC AND EPIGENETIC CAUSES OF OBESITY.

Authors:  Vidhu V Thaker
Journal:  Adolesc Med State Art Rev       Date:  2017

Review 6.  Obesity and lipodystrophy--where do the circles intersect?

Authors:  Farid F Chehab
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

7.  Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice.

Authors:  E Kokkotou; D O Espinoza; D Torres; I Karagiannides; S Kosteletos; T Savidge; M O'Brien; C Pothoulakis
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

8.  Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents.

Authors:  Yukihiko Shirayama; Shigeyuki Chaki
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

Review 9.  The role of melanin-concentrating hormone in energy homeostasis and mood disorders.

Authors:  Ildiko Antal-Zimanyi; Xavier Khawaja
Journal:  J Mol Neurosci       Date:  2009-05-06       Impact factor: 3.444

10.  The role of melanin-concentrating hormone and its receptors in energy homeostasis.

Authors:  Douglas J Macneil
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-22       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.